GLP1R and type 2 diabetes mellitus: The present study investigated the efficacy and safety of dulaglutide, a GLP-1 receptor agonist, in reducing body weight and improving glycemic control in a sample of 133 Saudi patients with type 2 diabetes mellitus (T2DM).